Lord Clement-Jones – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Lord Clement-Jones on 2016-02-24.

To ask Her Majesty’s Government, under the new Cancer Drugs Fund, what steps will be taken to secure early patient access to cancer medicines with Promising Innovative Medicines designation that have successfully passed through the Medicines and Healthcare products Regulation Agency’s Early Access to Medicines Scheme.

Lord Prior of Brampton

NHS England has advised that, under the proposals considered and approved by NHS England’s Board on 25 February 2016, the new Cancer Drugs Fund will provide access at drug launch for drug/indications which have a draft National Institute for Health and Care Excellence recommendation for use including those drugs that have successfully been through the Early Access to Medicines Scheme.